Business Description
Hangzhou Biotest Biotech Co Ltd
ISIN : CNE1000050H0
Share Class Description:
SHSE:688767: Class ACompare
Compare
Traded in other countries / regions
688767.China IPO Date
2021-09-08Description
Hangzhou Biotest Biotech Co Ltd is engaged in the research and development, manufacturing, sales and service of in vitro diagnostic reagents, raw materials and instruments.
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 825.58 | |||||
Equity-to-Asset | 0.94 | |||||
Debt-to-EBITDA | 0.02 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 13.01 | |||||
Beneish M-Score | -2.02 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -27.4 | |||||
3-Year EBITDA Growth Rate | -40.6 | |||||
3-Year EPS without NRI Growth Rate | -48.8 | |||||
3-Year FCF Growth Rate | -47.5 | |||||
3-Year Book Growth Rate | 59.8 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 50.97 | |||||
9-Day RSI | 50.56 | |||||
14-Day RSI | 48.94 | |||||
6-1 Month Momentum % | -7.46 | |||||
12-1 Month Momentum % | -6.19 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 13.6 | |||||
Quick Ratio | 13.02 | |||||
Cash Ratio | 12.51 | |||||
Days Inventory | 171.37 | |||||
Days Sales Outstanding | 45.79 | |||||
Days Payable | 90.9 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 3.08 | |||||
Dividend Payout Ratio | 1.29 | |||||
Forward Dividend Yield % | 3.08 | |||||
5-Year Yield-on-Cost % | 3.08 | |||||
3-Year Average Share Buyback Ratio | -10.1 | |||||
Shareholder Yield % | 3.16 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 50.38 | |||||
Operating Margin % | 20.44 | |||||
Net Margin % | 28.34 | |||||
FCF Margin % | -1.58 | |||||
ROE % | 5.5 | |||||
ROA % | 5.18 | |||||
ROIC % | 13.84 | |||||
ROC (Joel Greenblatt) % | 37.54 | |||||
ROCE % | 5.14 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 20.34 | |||||
PE Ratio without NRI | 15.18 | |||||
PEG Ratio | 0.26 | |||||
PS Ratio | 5.75 | |||||
PB Ratio | 1.14 | |||||
Price-to-Tangible-Book | 1.25 | |||||
Price-to-Operating-Cash-Flow | 13.19 | |||||
EV-to-EBIT | 7.95 | |||||
EV-to-EBITDA | 7.95 | |||||
EV-to-Revenue | 2.12 | |||||
EV-to-FCF | -139.33 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.4 | |||||
Price-to-Graham-Number | 0.92 | |||||
Price-to-Net-Current-Asset-Value | 1.56 | |||||
Price-to-Net-Cash | 1.71 | |||||
Earnings Yield (Greenblatt) % | 12.58 | |||||
FCF Yield % | -0.27 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hangzhou Biotest Biotech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 474.052 | ||
EPS (TTM) (Â¥) | 1.27 | ||
Beta | 0 | ||
Volatility % | 24.7 | ||
14-Day RSI | 48.94 | ||
14-Day ATR (Â¥) | 0.889415 | ||
20-Day SMA (Â¥) | 25.477 | ||
12-1 Month Momentum % | -6.19 | ||
52-Week Range (Â¥) | 22.23 - 36.7 | ||
Shares Outstanding (Mil) | 106.67 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Hangzhou Biotest Biotech Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Hangzhou Biotest Biotech Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Hangzhou Biotest Biotech Co Ltd Frequently Asked Questions
What is Hangzhou Biotest Biotech Co Ltd(SHSE:688767)'s stock price today?
The current price of SHSE:688767 is ¥25.83. The 52 week high of SHSE:688767 is ¥36.70 and 52 week low is ¥22.23.
When is next earnings date of Hangzhou Biotest Biotech Co Ltd(SHSE:688767)?
The next earnings date of Hangzhou Biotest Biotech Co Ltd(SHSE:688767) is .
Does Hangzhou Biotest Biotech Co Ltd(SHSE:688767) pay dividends? If so, how much?
The Dividend Yield %  of Hangzhou Biotest Biotech Co Ltd(SHSE:688767) is 3.08% (As of Today), Highest Dividend Payout Ratio of Hangzhou Biotest Biotech Co Ltd(SHSE:688767) was 2.97. The lowest was 0.42. And the median was 1.7. The  Forward Dividend Yield % of Hangzhou Biotest Biotech Co Ltd(SHSE:688767) is 3.08%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |